Photys Therapeutics’ proprietary bifunctional small molecules platform unlocks fine-tuned control of protein post-translational modifications, going beyond degradation to restore protein function, repair signaling, and amplify endogenous disease-fighting mechanisms. Photys was co-founded by the Broad Institute’s leading bifunctional chemist, Amit Choudhary, and the Longwood Fund, alongside a scientific advisory board comprised of distinguished scientists and drug developers – MIT’s Angela Koehler, Salk’s Tony Hunter, Berkeley’s Dan Nomura, MPM’s Wendy Young, and Dana Farber’s Eric Fischer.

Photys

(To Be Hired)

Bryan Song

Ed Holson

Emma Seabrook

The Scientific Team at Photys Therapeutics is responsible for advancing the development of bifunctional small molecules that precisely control protein post-translational modifications. This team, comprising experts in chemistry, biophysics, biology, medicinal chemistry, and proteomics, works collaboratively to restore protein function, repair signaling pathways, and enhance the body's natural disease-fighting mechanisms. Their collective research and innovative approaches drive the discovery and optimization of novel therapeutic agents.

Scientific Team

About

Team members

Other teams at Photys

Administrative and Support

Leadership Team